Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Xu, Xin ^a   Wu, Jian ^a   Mao, Yeqing ^a   Zhu, Yi ^a   Hu, Zhenghui ^a   Xu, Xianglai ^a   Lin, Yiwei ^a   Chen, Hong ^a   Zheng, Xiangyi ^a   Qin, Jie ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HUMAN; SELF REPORT; SMOKING; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW; COMORBIDITY; DIABETES COMPLICATIONS; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; REPRODUCIBILITY; RISK FACTOR; URINARY BLADDER NEOPLASMS;

COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84874631928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058079     Document Type: Article

References (49)

1. Ploeg M, Aben KK, Kiemeney LA, (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289-293.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, et al. (2012) Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
5. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, et al. (2007) Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25: 285-295.
6. Ren HB, Yu T, Liu C, Li YQ, (2011) Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 22: 837-847.
7. Yang WS, Va P, Bray F, Gao S, Gao J, et al. (2011) The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 6: e27326.
8. Larsson SC, Wolk A, (2011) Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia 54: 1013-1018.
9. Ben Q, Xu M, Ning X, Liu J, Hong S, et al. (2011) Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 47: 1928-1937.
10. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, et al. (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106: 1911-1921; quiz 1922.
11. Larsson SC, Orsini N, Brismar K, Wolk A, (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49: 2819-2823.
12. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
13. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, et al. (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7: 253-259.
14. Larsson SC, Andersson SO, Johansson JE, Wolk A, (2008) Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 44: 2655-2660.
15. Ogunleye AA, Ogston SA, Morris AD, Evans JM, (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101: 1199-1201.
16. Hemminki K, Li X, Sundquist J, Sundquist K, (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15: 548-555.
17. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA, (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128: 635-643.
18. Woolcott CG, Maskarinec G, Haiman CA, Henderson BE, Kolonel LN, (2011) Diabetes and urothelial cancer risk: the Multiethnic Cohort study. Cancer Epidemiol 35: 551-554.
19. Wotton CJ, Yeates DG, Goldacre MJ, (2011) Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies. Diabetologia 54: 527-534.
20. Lo SF, Chang SN, Muo CH, Chen SY, Liao FY, et al. (2012) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer.
21. Attner B, Landin-Olsson M, Lithman T, Noreen D, Olsson H, (2012) Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes Control 23: 769-777.
22. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
23. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
24. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
25. Tseng CH, (2011) Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 54: 2009-2015.
26. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314.
27. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ, (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167.
28. Tseng CH, Chong CK, Tseng CP, Chan TT, (2009) Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Ann Med 41: 371-379.
29. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, et al. (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 95: 1797-1800.
30. Shu X, Ji J, Li X, Sundquist J, Sundquist K, et al. (2010) Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 27: 791-797.
31. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202.
32. Tripathi A, Folsom AR, Anderson KE, (2002) Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95: 2316-2323.
33. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365.
34. Ragozzino M, Melton LJ, 3rd, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35: 13-19.
35. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, et al. (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92: 2070-2075.
36. Chaturvedi AK, Mbulaiteye SM, Engels EA, (2008) Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol 18: 230-234.
37. Jones ME, Swerdlow AJ, (1998) Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol 148: 1012-1017.
38. Key TJ, Appleby PN, Reeves GK, Roddam AW, (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11: 530-542.
39. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, et al. (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126: 1702-1715.
40. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, et al. (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol 169: 714-717.
41. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, et al. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57: 4667-4672.
42. Funfstuck R, Nicolle LE, Hanefeld M, Naber KG, (2012) Urinary tract infection in patients with diabetes mellitus. Clin Nephrol 77: 40-48.
43. Chen HS, Su LT, Lin SZ, Sung FC, Ko MC, et al. (2012) Increased risk of urinary tract calculi among patients with diabetes mellitus-a population-based cohort study. Urology 79: 86-92.
44. Jankovic S, Radosavljevic V, (2007) Risk factors for bladder cancer. Tumori 93: 4-12.
45. Chow WH, Lindblad P, Gridley G, Nyren O, McLaughlin JK, et al. (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89: 1453-1457.
46. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57: 1096-1103.
47. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, et al. (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5: 240-247.
48. Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, et al. (2012) Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia 55: 1953-1962.
49. Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, et al. (2012) The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ 344: e3645.